Advertisement
UK markets close in 7 hours 46 minutes
  • FTSE 100

    7,897.28
    +49.29 (+0.63%)
     
  • FTSE 250

    19,385.41
    +45.27 (+0.23%)
     
  • AIM

    742.93
    -0.19 (-0.03%)
     
  • GBP/EUR

    1.1675
    +0.0008 (+0.07%)
     
  • GBP/USD

    1.2478
    +0.0022 (+0.18%)
     
  • Bitcoin GBP

    48,901.95
    -2,008.14 (-3.94%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,022.21
    -29.20 (-0.58%)
     
  • DOW

    37,753.31
    -45.66 (-0.12%)
     
  • CRUDE OIL

    82.10
    -0.59 (-0.71%)
     
  • GOLD FUTURES

    2,390.50
    +2.10 (+0.09%)
     
  • NIKKEI 225

    38,079.70
    +117.90 (+0.31%)
     
  • HANG SENG

    16,416.56
    +164.72 (+1.01%)
     
  • DAX

    17,820.43
    +50.41 (+0.28%)
     
  • CAC 40

    8,029.81
    +48.30 (+0.61%)
     

A Drug Program That Keeps Patients Safe (And Profits, Too)

A Drug Program That Keeps Patients Safe (And Profits, Too)

For generic drug companies, manufacturing low-cost alternatives to brand-name medicines is the easy part. The hard part: getting their hands on the drugs they want to copy.